Physician profile
Sherrilynn Parrish
NPI 1477531382
$2,130.80
in general payments reported to CMS, 2019-2025
22 companies · $887 in 2025
The $887 reported for 2025 was more than what 91% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $88.53 · 2021: $23.81 · 2022: $17.17 · 2023: $465 · 2024: $411 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Education: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.02 |
| Education | $340.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $423.78 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $308.92 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $296.99 | 2023-2025 | Myfembree, Gemtesa |
| Exact Sciences Corporation | $239.30 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $199.04 | 2019-2025 | |
| Coopersurgical, INC. | $97.40 | 2022-2025 | Paragard T 380a |
| Abbvie INC. | $89.80 | 2019-2021 | |
| Exeltis, USA INC. | $70.72 | 2021-2025 | Slynd |
| Organon LLC | $68.02 | 2024-2025 | Nexplanon |
| Ethicon US, LLC | $59.40 | 2019-2020 | |
| Therapeuticsmd, INC. | $41.20 | 2019-2020 | |
| Evofem Biosciences, INC. | $38.72 | 2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $32.15 | 2019-2025 | Aptima |
| Merck Sharp & Dohme LLC | $28.77 | 2025 | Gardasil 9 |
| Millicent US INC | $27.22 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $25.54 | 2019-2020 | |
| Boston Scientific Corporation | $15.83 | 2023 | |
| Sage Therapeutics, LLC | $15.32 | 2025 | Zurzuvae |
| Amgen INC. | $14.66 | 2019 | |
| Daiichi Sankyo INC. | $13.42 | 2019 | |
| Lupin INC. | $13.17 | 2019 | |
| Covidien LP | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherrilynn Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.